An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome
Primary Purpose
Premenstrual Syndrome
Status
Completed
Phase
Phase 2
Locations
South Africa
Study Type
Interventional
Intervention
Individualised Homeopathic Remedy
Sponsored by
About this trial
This is an interventional treatment trial for Premenstrual Syndrome focused on measuring PMS, Individualised homoeopathic treatment, Indian females
Eligibility Criteria
Inclusion Criteria:
- Females between ages of 18 and 40 years who experience PMS on a monthly basis;
- females who experience an increase in at least one of the following mental and physical symptoms at least fourteen days before their menses begin, in each of the three preceding menstrual cycles: Mental symptoms: irritability, depression or anxiety Physical symptoms: breast tenderness or swelling, abdominal bloating, headaches, swelling of extremities or food cravings; and
- females who have an amelioration of the above symptoms within three days of the onset of menses and symptoms should not reoccur until at least day thirteen of the cycle.
Exclusion Criteria:
- Irregular menstrual cycles;
- lactating females;
- prediagnosed anxiety and depression;
- use of sex hormones except the oral contraceptive (must have been used for a minimum of 3 months) or concomitant psychotherapies and alternate therapies for PMS
- pregnant females
Sites / Locations
- University of Johannesburg
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Individualised Homoeopathic Remedy
Arm Description
Each participant will receive an individualised homoeopathic remedy, in a vehicle of sucrose pillules, according to the symptoms of their PMS. Although different individualised remedies may be dispensed, each remedy will be homoeopathic. Each individualised homoeopathic remedy will have an individualised dosage, frequency and duration based on the laws of individualised homoeopathic prescribing as outlined by De Schepper.
Outcomes
Primary Outcome Measures
PMS symptoms severity on PMS chart
The PMS chart will be completed every day for 12 weeks, recording the participant's symptoms based on the most characteristic PMS symptoms and has been used in previous PMS studies. The evaluation of symptoms is subjective and is based on a 5 point scale: 0 - "no symptom", 1- "very mild", 2 - "mild", 3 - "severe", 4 - "extremely severe".
Secondary Outcome Measures
Case notes on patient symptoms and wellbeing
Qualitative data will be collected by the researcher from the participant at weeks 0, 4, 8 and 12 using case notes.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02467088
Brief Title
An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome
Official Title
An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome in Indian Females
Study Type
Interventional
2. Study Status
Record Verification Date
May 2016
Overall Recruitment Status
Completed
Study Start Date
August 2014 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
August 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Johannesburg
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Premenstrual Syndrome (PMS) is a group of physical, mental and behavioural symptoms that occur cyclically through the luteal phase of the menstrual cycle and resolve within three days of the onset of menstruation. Many women are affected by the physical and psychological symptoms of PMS. The symptoms of PMS can change behaviour and wellbeing of women which has an impact on families, social life and work. Research has shown that women with PMS reported additional days missed at work compared to women that do not suffer with PMS. A study done by Brohi et al. (2011) showed that PMS is a common problem that occurs in 81.25% of women and has an adverse impact on a woman's quality of life. Conventional treatment is limited, not always effective and is associated with many side effects. Research using individualised homeopathic treatment, known as the homeopathic similimum, in PMS has shown to be well tolerated as well as have a positive impact on the symptoms of PMS although further research is warranted in this regard. There have not been any studies done on homeopathic treatment in Indian females in South Africa.
The aim of this study is to determine the effect of individualised homeopathic treatment on females of Indian origin who are suffering with symptoms of PMS, using observational studies.
Detailed Description
This study will be a 12 week observational study of an embedded mixed method design and will be conducted over 12 weeks, consisting of four consultations 4 weeks apart, at the Homeopathic Health Centre, University of Johannesburg Doornfontein Campus. Ten South African Indian females, between 18-40 years of age, who experience PMS symptoms will be recruited through the placement of advertisements placed at health stores, homoeopathic/medical practices and on the University campus (with the relevant permission granted).
Each participant must meet the criteria of the selection questionaire. In the first consultation, the researcher will explain the study to the participant. The participant will then be requested to sign the Participant Information and Consent Form. A full case history will be taken using a standard homeopathic case taking form. Each participant will be given a PMS chart to score their symptoms every day for the following 4 weeks in order to establish the baseline of each participant's premenstrual symptoms. No treatment will be prescribed in this period.
Participants will be reminded of their appointments via email and text message before every follow up consultation. Each follow-up consultation will consist of a homoeopathic case taking, relevant physical examination and the collection of the PMS-chart which was completed over the previous 4 weeks by the participant.
After each follow-up consultation, the researcher will establish the participant's individualised homoeopathic remedy according to the principles of classical homoeopathy by using the Complete Repertory 2014 provided in Mercurius® repertory software and the standard Materia Medica, with the guidance of the supervisor or co-supervisor. The potency and dosage of each remedy will be determined in accordance with the principles of individualised homoeopathic prescribing as described by De Schepper. The selected remedy will then be dispensed to the participant. No remedy will be dispensed at week 12. The participant will return a completed PMS-chart, completed over a 4 week period, to the researcher at weeks 4, 8 and 12.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Premenstrual Syndrome
Keywords
PMS, Individualised homoeopathic treatment, Indian females
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Individualised Homoeopathic Remedy
Arm Type
Experimental
Arm Description
Each participant will receive an individualised homoeopathic remedy, in a vehicle of sucrose pillules, according to the symptoms of their PMS. Although different individualised remedies may be dispensed, each remedy will be homoeopathic. Each individualised homoeopathic remedy will have an individualised dosage, frequency and duration based on the laws of individualised homoeopathic prescribing as outlined by De Schepper.
Intervention Type
Other
Intervention Name(s)
Individualised Homeopathic Remedy
Intervention Description
Each participant will receive an individualised homoeopathic remedy prescribed according to the individualised symptoms of their PMS.
Primary Outcome Measure Information:
Title
PMS symptoms severity on PMS chart
Description
The PMS chart will be completed every day for 12 weeks, recording the participant's symptoms based on the most characteristic PMS symptoms and has been used in previous PMS studies. The evaluation of symptoms is subjective and is based on a 5 point scale: 0 - "no symptom", 1- "very mild", 2 - "mild", 3 - "severe", 4 - "extremely severe".
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Case notes on patient symptoms and wellbeing
Description
Qualitative data will be collected by the researcher from the participant at weeks 0, 4, 8 and 12 using case notes.
Time Frame
12 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Females between ages of 18 and 40 years who experience PMS on a monthly basis;
females who experience an increase in at least one of the following mental and physical symptoms at least fourteen days before their menses begin, in each of the three preceding menstrual cycles: Mental symptoms: irritability, depression or anxiety Physical symptoms: breast tenderness or swelling, abdominal bloating, headaches, swelling of extremities or food cravings; and
females who have an amelioration of the above symptoms within three days of the onset of menses and symptoms should not reoccur until at least day thirteen of the cycle.
Exclusion Criteria:
Irregular menstrual cycles;
lactating females;
prediagnosed anxiety and depression;
use of sex hormones except the oral contraceptive (must have been used for a minimum of 3 months) or concomitant psychotherapies and alternate therapies for PMS
pregnant females
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Reshma Patel, MTech.Hom
Organizational Affiliation
University of Johannesburg
Official's Role
Study Director
Facility Information:
Facility Name
University of Johannesburg
City
Johannesburg
State/Province
Gauteng
ZIP/Postal Code
2094
Country
South Africa
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
An Observational Study on the Efficacy of Individualised Homoeopathic Treatment on Premenstrual Syndrome
We'll reach out to this number within 24 hrs